CD8A and COVID-19: In contrast, the S protein had limited epitopes, with only one epitope on the protein's receptor‐binding domain.[154, 155] These findings provide a better knowledge of CD8+ T cell reactivity in patients suffering from COVID‐19, along with a path to developing and manufacturing next‐generation vaccines.